Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Assembly Biosciences (ASMB)

Assembly Biosciences (ASMB)
10.03 x 5 10.40 x 2
Post-market by (Cboe BZX)
10.07 +0.13 (+1.31%) 04/22/25 [NASDAQ]
10.03 x 5 10.40 x 2
Post-market 10.07 unch (unch) 16:00 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
9.82
Day High
10.41
Open 9.98
Previous Close 9.94 9.94
Volume 16,300 16,300
Avg Vol 36,305 36,305
Stochastic %K 78.29% 78.29%
Weighted Alpha -33.11 -33.11
5-Day Change -0.13 (-1.27%) -0.13 (-1.27%)
52-Week Range 7.75 - 19.93 7.75 - 19.93
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 74,584
  • Shares Outstanding, K 7,503
  • Annual Sales, $ 28,520 K
  • Annual Income, $ -40,180 K
  • EBIT $ -45 M
  • EBITDA $ -49 M
  • 60-Month Beta 0.65
  • Price/Sales 2.64
  • Price/Cash Flow N/A
  • Price/Book 1.91

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -2.01
  • Number of Estimates 2
  • High Estimate -1.54
  • Low Estimate -2.47
  • Prior Year -1.66
  • Growth Rate Est. (year over year) -21.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.75 +29.94%
on 04/07/25
Period Open: 11.01
11.78 -14.52%
on 03/25/25
-0.94 (-8.54%)
since 03/21/25
3-Month
7.75 +29.94%
on 04/07/25
Period Open: 14.95
14.92 -32.51%
on 01/23/25
-4.88 (-32.64%)
since 01/22/25
52-Week
7.75 +29.94%
on 04/07/25
Period Open: 13.22
19.93 -49.47%
on 09/23/24
-3.15 (-23.83%)
since 04/22/24

Most Recent Stories

More News
Assembly Biosciences Presents New Data Highlighting Long-Acting Herpes Simplex Virus Candidate ABI-5366 and Genital Herpes Prevalence and Treatment Patterns at the 2025 ESCMID Congress

ASMB : 10.07 (+1.31%)
Assembly Biosciences Reports Year End 2024 Financial Results and Recent Highlights

ASMB : 10.07 (+1.31%)
Assembly Biosciences Doses First Participant in Phase 1a Clinical Study of Oral Entry Inhibitor Candidate ABI-6250 for Hepatitis Delta Virus

ASMB : 10.07 (+1.31%)
Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor ABI-1179 in Development for Recurrent Genital Herpes

ASMB : 10.07 (+1.31%)
Assembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 in Chronic Hepatitis B

ASMB : 10.07 (+1.31%)
Assembly Biosciences Announces $30.1 Million Equity Investment and Accelerated Funding from Gilead to Advance Clinical Development Programs

ASMB : 10.07 (+1.31%)
Insider Purchase: 10% owner at $ASMB (ASMB) Buys 17,024 Shares

Alexander Schornstein, a 10% owner of $ASMB ($ASMB), bought 17,024 shares of the company on 11-22-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased...

ASMB : 10.07 (+1.31%)
Assembly Biosciences: Q3 Earnings Snapshot

Assembly Biosciences: Q3 Earnings Snapshot

ASMB : 10.07 (+1.31%)
Assembly Biosciences Reports Third Quarter 2024 Financial Results and Recent Updates

ASMB : 10.07 (+1.31%)
Stocks Settle Mostly Lower on Chip Stock Weakness

The S&P 500 Index ($SPX ) (SPY ) Friday closed down by -0.19%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up by +0.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.24%. Stocks...

AMAT : 138.30 (+2.03%)
FRO : 14.97 (+0.74%)
ADI : 178.50 (+2.01%)
TXN : 146.76 (+0.79%)
$IUXX : 18,276.41 (+2.63%)
ASML : 638.69 (+2.24%)
ZNM25 : 110-265 (+0.03%)
GFS : 31.71 (+1.12%)
QCOM : 138.74 (+1.91%)
PBF : 15.68 (+1.88%)
VLO : 112.46 (+3.33%)
UPS : 96.84 (+0.61%)

Business Summary

Assembly Biosciences, Inc. is a biopharmaceutical company. It develops therapies for infectious diseases and other disorders of the gastrointestinal (GI) system. Assembly's product portfolio consists of two late stage assets: VEN 307 for relief from pain associated with anal fissures and VEN 308 for...

See More

Key Turning Points

3rd Resistance Point 10.97
2nd Resistance Point 10.69
1st Resistance Point 10.38
Last Price 10.07
1st Support Level 9.79
2nd Support Level 9.51
3rd Support Level 9.20

See More

52-Week High 19.93
Fibonacci 61.8% 15.28
Fibonacci 50% 13.84
Fibonacci 38.2% 12.40
Last Price 10.07
52-Week Low 7.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro